emergence agitation
Conditions
Interventions
Propofol Group:When the patient has awakening agitation, intravenous propofol 1 mg/kg treatment.
Remimazolam Group:When the patient has awakening agitation, intravenous remimazolam 0.1 mg/kg treatment.
Sponsors
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Qiaokou District, Wuhan City, Hubei Province
Eligibility
Sex/Gender
All
Age
2 Years to 12 Years
Inclusion criteria
Inclusion criteria: Children aged 2-12 years, ASA grade I.-II., and experienced awakening agitation after elective surgery were selected.
Exclusion criteria
Exclusion criteria: (1) Patients younger than 2 years old or older than 12 years old; (2) ASA classification =III.; (3) allergy to propofol or remazolam; (4) Preoperative pulmonary dysfunction (including pneumonia, acute lung injury, acute respiratory distress syndrome, etc.); (5) preoperative cardiac dysfunction; (6) Preoperative liver and kidney dysfunction; (7) Have a history of mental illness; (8) Patients with developmental delay and neurological disorders; (9) Patients who have participated in other studies within 90 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficient; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rate of agitation after intervention;the length of stay in PACU;Incidence of respiratory depression;Incidence of laryngospasm; | — |
Countries
CHINA
Contacts
Public ContactFang Luo
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Qiaokou District, Wuhan City, Hubei Province
Outcome results
None listed